bioarray beadchip (Bioarray Inc)
90
Structured Review
Bioarray Inc
bioarray beadchip
Bioarray Beadchip, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bioarray+beadchip/bioarray+hea+beadchip/us09556483-218-26-27
Average 90 stars, based on 1 article reviews
Bioarray Beadchip, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bioarray+beadchip/bioarray+hea+beadchip/us09556483-218-26-27
Average 90 stars, based on 1 article reviews
bioarray beadchip - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Amplification:Article Title: Noninvasive buccal swab antigen sample and molecular testing provides extended antigen typing for patients with hemoglobinopathies. Article Snippet: Objective To demonstrate the feasibility of performing a noninvasive, molecular-based red blood cell (RBC) antigen test on infants and very young children with sickle cell disease as part of a statewide newborn screening follow-up program.. Study design A prospective pilot project was conducted using a noninvasive buccal swab and test kit to perform DNA-based, extended RBC phenotyping in 92 children participating in a newborn hemoglobinopathy screening follow-up program.. Reported data include the extended panel of antigens detected by molecular analysis compared with unaffected population estimates. Multiplex Assay:Article Title: Noninvasive buccal swab antigen sample and molecular testing provides extended antigen typing for patients with hemoglobinopathies. Article Snippet: Objective To demonstrate the feasibility of performing a noninvasive, molecular-based red blood cell (RBC) antigen test on infants and very young children with sickle cell disease as part of a statewide newborn screening follow-up program.. Study design A prospective pilot project was conducted using a noninvasive buccal swab and test kit to perform DNA-based, extended RBC phenotyping in 92 children participating in a newborn hemoglobinopathy screening follow-up program.. Reported data include the extended panel of antigens detected by molecular analysis compared with unaffected population estimates. Polymerase Chain Reaction:Article Title: Noninvasive buccal swab antigen sample and molecular testing provides extended antigen typing for patients with hemoglobinopathies. Article Snippet: Objective To demonstrate the feasibility of performing a noninvasive, molecular-based red blood cell (RBC) antigen test on infants and very young children with sickle cell disease as part of a statewide newborn screening follow-up program.. Study design A prospective pilot project was conducted using a noninvasive buccal swab and test kit to perform DNA-based, extended RBC phenotyping in 92 children participating in a newborn hemoglobinopathy screening follow-up program.. Reported data include the extended panel of antigens detected by molecular analysis compared with unaffected population estimates. Article Title: Abstracts of the AABB Annual Meeting and CTTXPO. Boston, Massachusetts, USA. October 6-9, 2012. Article Snippet: Scientifi c Section Article Title: International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study. Article Snippet: J. Boyle, S. J. Thorpe, J. R. Hawkins, C. Lockie, B.. Fox, P. Matejtschuk, C. Halls, P. Metcalfe, P. Rigsby, S. Armstrong-Fisher, A. M. Varzi,* S. Urbaniak & G. Daniels National Institute for Biological Standards and Control (NIBSC), Potters Bar, Herts, UK Academic Transfusion Medicine Unit, Division of Applied Medicine, SNBTS Blood Transfusion Centre, Aberdeen, UK International Blood Group Reference Laboratory, NHSBT, Bristol, UK Automated Assay:Article Title: Noninvasive buccal swab antigen sample and molecular testing provides extended antigen typing for patients with hemoglobinopathies. Article Snippet: Objective To demonstrate the feasibility of performing a noninvasive, molecular-based red blood cell (RBC) antigen test on infants and very young children with sickle cell disease as part of a statewide newborn screening follow-up program.. Study design A prospective pilot project was conducted using a noninvasive buccal swab and test kit to perform DNA-based, extended RBC phenotyping in 92 children participating in a newborn hemoglobinopathy screening follow-up program.. Reported data include the extended panel of antigens detected by molecular analysis compared with unaffected population estimates. Microscopy:Article Title: Methods of screening for binding interaction using sets of microparticles and unique probes Article Snippet: .. Detection of fluorescent labels may also be carried out using a microscope or camera that will read the image on the microparticles, such as the Article Title: Methods of detecting alloantibodies using HLA and non-HLA antigens Article Snippet: .. Detection of fluorescent labels may also be carried out using a microscope or camera that will read the image on the microparticles, such as the Variant Assay:Article Title: Abstracts of the AABB Annual Meeting and CTTXPO. Boston, Massachusetts, USA. October 6-9, 2012. Article Snippet: Scientifi c Section other:Article Title: Abstracts of the AABB Annual Meeting and CTTXPO. Denver, Colorado, USA. October 12-15, 2013. Article Snippet: Presentations from the AABB Annual Meeting and CTTXPO, Denver, CO, October 12-15, 2013 Article Title: The impact of Daratumumab on transfusion service costs. Article Snippet: BACKGROUND: Daratumumab (DARA) is a human IgG1κ monoclonal antibody directed against CD38, approved for the treatment of multiple myeloma.. As CD38 is expressed on RBCs, DARA can interfere with pretransfusion testing.. DARA interference can be negated by denaturation of CD38 on RBCs with dithiothreitol (DTT) reagents. |
